JPRN-UMIN000024818
Completed
N/A
The efficacy and safety of botulinum toxin type B on digital ulcers in patients with systemic sclerosis - The efficacy and safety of BTX-B on digital ulcers in patients with SSc
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- digital ulcers in systemic sclerosis patients
- Sponsor
- Gunma University Hospital
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients under the age 18, with the pregnancy or having the past medical histories with BTX were excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
How safe is the use of Botulinum Toxin type A in the treatment of Masseter Hypertrophy?Masseter muscleSkeletal Muscle HypertrophyRBR-7tdjcn5Faculdade Ingá - UNINGÁ/Paraná
Recruiting
Phase 2
Evaluation of the effectiveness of botulinum toxin in preventing hypertrophic scarringIRCT20100314003566N15Tabriz University of Medical Sciences30
Completed
Phase 1
The effect of botulinum toxin type A on reducing salivation and quality of life in patients with cerebral palsyCerebral palsy.Cerebral palsyIRCT20220516054868N1Esfahan University of Medical Sciences30
Recruiting
Phase 1
Safety and efficacy of botulinum toxin A (Botox) in patients with trigeminal neuralgiaTrigeminal neuralgiaMedDRA version: 20.0Level: PTClassification code: 10044652Term: Trigeminal neuralgia Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]CTIS2023-504567-17-00Rigshospitalet80
Recruiting
Phase 2
Botulinum toxin type A for plantar hyperhidrosisplantar hyperhidrosisJPRN-jRCTs041210062Ohshima Yuichiro40